Acute chest pain (ACP) is a common presentation in emergency departments worldwide, demanding a meticulous and systematic approach from healthcare professionals. The complexity of ACP necessitates a comprehensive understanding of its varied etiologies and the importance of timely intervention.
ACP can stem from a myriad of causes, ranging from benign musculoskeletal issues to life-threatening conditions like acute myocardial infarction (AMI), pulmonary embolism, or aortic dissection. An accurate differential diagnosis is crucial in guiding subsequent management strategies.
The initial assessment of a patient with ACP includes a detailed history, physical examination, and appropriate investigations. The aim is to identify high-risk features suggestive of serious pathology. These include features of AMI, such as radiation of pain, associated symptoms like shortness of breath, and risk factors for coronary artery disease.
Investigations such as an electrocardiogram (ECG) and cardiac biomarkers play a pivotal role in diagnosing cardiac causes of ACP. The management of ACP is tailored according to the underlying cause. For suspected AMI, immediate reperfusion therapy is recommended, while other causes may require specific interventions or supportive care.
Managing ACP in a clinical setting involves an intricate process of systematic assessment, accurate diagnosis, and appropriate intervention. The challenge lies in differentiating between benign and life-threatening causes, necessitating a high level of clinical acumen. Continuous medical education and updated guidelines are essential tools in enhancing the healthcare professional's skill set in managing this common but complex clinical presentation.
1.
Cancer tumor anatomy influences the benefits of chemotherapy for patients with early-stage breast cancer.
2.
FDA Investigating Blood Cancer Risk With Gene Therapy Skysona
3.
Adding Lenvatinib to Pembro Ups PFS in Head and Neck Cancer
4.
In early dementia, SSRIs enhance cognition and major depression.
5.
TCL1A Protein Identified as Predictor of Blinatumomab Response in Relapsed B-ALL
1.
Oncologic Emergencies: Diagnosis and Treatment
2.
Strategic Standards in Hematology for Specialists
3.
Emerging Chemo-Immunotherapy: New Agents and Mechanisms in Modern Oncology
4.
Advanced Breakthroughs in Hematology and Patient Outcomes
5.
Multidisciplinary Insights into Diagnosis, Management, and Outcomes in Oncology
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
Asian Symposium on Advancement in Hematology and Oncology
4.
International Cancer Conference
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Navigating the Complexities of Ph Negative ALL - Part IX
2.
A Continuation to The Evolving Landscape of First-Line Treatment for Urothelial Carcinoma
3.
Current Scenario of Cancer- An Overview of The Incidence of Cancer in Men
4.
Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part II
5.
Pazopanib: A Game-Changer in Managing Advanced Renal Cell Carcinoma - Part III
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation